JNJ JOHNSON & JOHNSON Earnings Reports 8-K Filing 2024 - Earnings Report Johnson & Johnson reported a quarterly earnings increase of 5% to $24.8 billion, driven by strong sales in its pharmaceutical division, while adjusting its full-year guidance upwards.Get access to all SEC 8-K filings of the JOHNSON & JOHNSON